COVID-19

Systems-level immunomonitoring of severe COVID-19

A longitudinal, systems-level approach characterizes cellular and protein immune responses in severe COVID-19, and during the recovery phase following severe disease.

Protein biomarkers of COVID-19 pathophysiology (Radboud UMC)

A team from the Netherlands used targeted proteomics to find inflammatory and other biomarkers that characterize COVID-19 and the severity of the disease.

A rare but severe complication in children with COVID-19

A study by Petter Brodin's group at the Karolinska Institute sheds new light on Inflammatory Syndrome in Children (MIS-C). The results were published in Cell.

Longitudinal COVID-19 proteomics study from MGH

Olink is immensely proud of our contribution to one of the largest longitudinal COVID-19 studies together with the prestigious Massachusetts General Hospital (MGH).